Journal Article DKFZ-2020-01112

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Contrast agent accumulation patterns in chronic interstitial lung disease using 5d MRI.

 ;  ;  ;  ;  ;  ;

2020
Wiley Bognor Regis

BJR 93(1113), 20190121 () [10.1259/bjr.20190121]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: To analyse delayed contrast dynamics of fibrotic lesions in interstitial lung disease (ILD) using 5D MRI and to correlate contrast dynamics with disease severity.20 patients (mean age: 71 years; M:F, 13:7), with chronic fibrosing ILD: n = 12 idiopathic pulmonary fibrosis (IPF) and n = 8 non-IPF, underwent thin-section multislice CT as part of the standard diagnostic workup and additionally MRI of the lung. Two minutes after contrast injection, a radial gradient echo sequence with golden-angle spacing was acquired during 5 min of free-breathing, followed by 5D image reconstruction. Disease was categorized as severe or non-severe according to CT morphological regional severity. For each patient 10 lesions were analysed.IPF lesions showed later peak enhancement compared to non-IPF (severe: p = 0.01, non-severe: p = 0.003). Severe lesions showed later peak enhancement compared to non-severe lesions, in non-IPF (p = 0.04), but not in IPF (p = 0.35). There was a tendency towards higher accumulation and washout rates in IPF compared to non-IPF in non-severe disease. Severe lesions had lower wash-out rate than non-severe ones in both IPF (p = 0.003) and non-IPF (p = 0.005). Continuous contrast agent accumulation, without wash-out, was found only in IPF lesions.Contrast agent dynamics are influenced by type and severity of pulmonary fibrosis, which might enable a more thorough characterization of disease burden. The regional impairment is of particular interest in the context of antifibrotic treatments and was characterized using a non-invasive, non-irradiating, free-breathing method.Delayed contrast enhancement patterns allow the assessment of regional lung impairment which could represent different disease stages or phenotypes in ILD.

Classification:

Note: 2020 Sep 1;93(1113):20190121

Contributing Institute(s):
  1. E025 Röntgenbildgebung und Computertomographie (E025)
  2. E020 Med. Physik in der Radiologie (E020)
Research Program(s):
  1. 315 - Imaging and radiooncology (POF3-315) (POF3-315)

Appears in the scientific report 2020
Database coverage:
Medline ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > E025
Institute Collections > E020
Public records
Publications database

 Record created 2020-07-06, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)